13 Americans Per Day On Transplant List; Bipartisan Bill Seeks To Cover Donor Costs

Urgent Push To Cut Donor Costs: New Bill Seeks Broader Reimbursement For Living Organ Donors

USA: A stark tally — 13 Americans die every day while waiting for an organ transplant — frames a renewed push to remove financial barriers to living donation. A lawmaker announcing a package of changes says the current system adds economic strain to would‑be donors and threatens the supply of organs and tissues relied upon by patients on the waiting list. The proposal is presented as a practical effort to make living donation a more attainable option for families and communities across the country.

At the center of the measure is reform of the living organ donation reimbursement program. Advocates point to existing realities in which living donors often shoulder out‑of‑pocket expenses that can exceed $10,000, a level the sponsor notes as unsustainable for many people. The bipartisan Honoring Our Living Donors Act is designed to widen eligibility so more donors can recoup wage losses, travel expenditures, and costs associated with hiring caregivers during recovery, thereby reducing the direct financial hit of donation.

The bill’s backers argue that expanding reimbursement is an immediate step that can be implemented quickly, and they stress urgency in moving the reforms forward. While the legislation targets specific categories of expense — wages, travel, caregiver support — the sponsor also cautioned that passage of the bill would not complete the work. More effort will be required to ensure the broader organ donation system operates effectively and equitably for donors and recipients alike.

The stated intent is straightforward: lower the economic hurdles that deter living donors and strengthen pathways to transplantation for patients on waiting lists. By tackling the financial disincentives that accompany donation, proponents say the reform could help stabilize donor supply and give more Americans access to life‑saving transplants. The measure remains a focal point in ongoing discussions about how best to support donors and address the persistent shortfall in organs and tissues.